Covered recipient · General Payments record
TIFFANY L GORMAN
Allopathic & Osteopathic Physicians Family Medicine Sports Medicine
General Payments · PY2018–2024
$4,918.35
- Reported across 335 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $892.71 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $333.43 | 26 |
| GlaxoSmithKline, LLC. | $181.19 | 10 |
| Novo Nordisk AS | $109.24 | 5 |
| PFIZER INC. | $105.85 | 5 |
| Exact Sciences Corporation | $45.58 | 2 |
| Lilly USA, LLC | $36.33 | 2 |
| Astellas Pharma US Inc | $32.93 | 1 |
| Amgen Inc. | $32.48 | 1 |
| Bioventus LLC | $15.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.19 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823004 | CMS |
| ABBVIE INC. | $19.65 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823006 | CMS |
| ABBVIE INC. | $13.66 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823008 | CMS |
| ABBVIE INC. | $8.87 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823010 | CMS |
| ABBVIE INC. | $14.95 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823012 | CMS |
| ABBVIE INC. | $26.31 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823014 | CMS |
| ABBVIE INC. | $8.30 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823016 | CMS |
| ABBVIE INC. | $18.86 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823018 | CMS |
| ABBVIE INC. | $21.97 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823020 | CMS |
| ABBVIE INC. | $18.17 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823022 | CMS |
| ABBVIE INC. | $7.12 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823024 | CMS |
| ABBVIE INC. | $13.12 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823026 | CMS |
| ABBVIE INC. | $23.39 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823028 | CMS |
| ABBVIE INC. | $11.85 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823030 | CMS |
| ABBVIE INC. | $16.50 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823032 | CMS |
| ABBVIE INC. | $20.78 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823034 | CMS |
| ABBVIE INC. | $7.37 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823036 | CMS |
| ABBVIE INC. | $5.79 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823038 | CMS |
| ABBVIE INC. | $21.71 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823040 | CMS |
| ABBVIE INC. | $10.84 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823042 | CMS |
| ABBVIE INC. | $8.24 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823044 | CMS |
| ABBVIE INC. | $4.12 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823046 | CMS |
| ABBVIE INC. | $7.04 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823048 | CMS |
| ABBVIE INC. | $3.66 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823050 | CMS |
| ABBVIE INC. | $10.25 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823052 | CMS |
| ABBVIE INC. | $3.72 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103823054 | CMS |
| Amgen Inc. | $32.48 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115672528 | CMS |
| Astellas Pharma US Inc | $32.93 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139270198 | CMS |
| Bioventus LLC | $15.68 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137440958 | CMS |
| Exact Sciences Corporation | $22.79 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114680051 | CMS |
| Exact Sciences Corporation | $22.79 | 09/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114680057 | CMS |
| GlaxoSmithKline, LLC. | $24.02 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116195463 | CMS |
| GlaxoSmithKline, LLC. | $28.33 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116368079 | CMS |
| GlaxoSmithKline, LLC. | $25.21 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116242836 | CMS |
| GlaxoSmithKline, LLC. | $21.09 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116379962 | CMS |
| GlaxoSmithKline, LLC. | $7.60 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116461464 | CMS |
| GlaxoSmithKline, LLC. | $23.62 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116083003 | CMS |
| GlaxoSmithKline, LLC. | $26.90 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116483061 | CMS |
| GlaxoSmithKline, LLC. | $4.85 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116268700 | CMS |
| GlaxoSmithKline, LLC. | $18.15 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116275505 | CMS |
| GlaxoSmithKline, LLC. | $1.42 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116586739 | CMS |
| Lilly USA, LLC | $18.40 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135479955 | CMS |
| Lilly USA, LLC | $17.93 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135464546 | CMS |
| Novo Nordisk Inc | $25.00 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096863427 | CMS |
| Novo Nordisk Inc | $18.14 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096826993 | CMS |
| Novo Nordisk Inc | $18.10 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096611582 | CMS |
| Novo Nordisk Inc | $30.31 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097498154 | CMS |
| Novo Nordisk Inc | $17.69 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096633953 | CMS |
| PFIZER INC. | $14.10 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131579119 | CMS |
| PFIZER INC. | $24.37 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131867398 | CMS |
| PFIZER INC. | $23.06 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130884560 | CMS |
| PFIZER INC. | $25.46 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131965715 | CMS |
| PFIZER INC. | $18.86 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131099682 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.